Comparison and Correlation of Two Proposed PML Risk Stratification Biomarkers for Long-term Natalizumab Treatment, Anti-JCV Antibody Index and L-selection (CD62L): A Retrospective Study
Schwab N, Schneider-Hohendorf T, Breuer J, Posevitz-Fejfar A, Wiendl H, Posevitz-Fejfar A
Research article (journal) | Peer reviewedDetails about the publication
Journal: Neurology
Volume: 83
Issue: 2
Status: Published
Release year: 2014
Language in which the publication is written: English
Authors from the University of Münster
| Breuer, Johanna | Department for Neurology |
| Posevitz Fejfar, Anita | Department for Neurology |
| Schneider-Hohendorf, Tilman | Department for Neurology |
| Schwab, Nicholas Christopher | Department for Neurology |
| Wiendl, Heinz Siegfried | Department for Neurology |